Form 4: ProAssurance Executive Shook Granted New Equity Awards

ProAssurance Corporation's subsidiary President, Kevin Merrick Shook, received a new grant of 23,720 Restricted Stock Units, adding to existing equity holdings.

Summary

• Kevin Merrick Shook, President of a subsidiary of ProAssurance Corporation (PRA), was granted 23,720 Restricted Stock Units (RSUs).
• This new RSU grant occurred on January 7, 2026, and will vest pro rata in one-third increments in 2027, 2028, and 2029.
• Each RSU represents a contingent right to receive one share of ProAssurance Corporation common stock, issuable from the 2014 Equity Incentive Compensation Plan.
• Vesting is contingent on continuous employment and can accelerate upon death, disability, or 'Good Reason' termination, as defined in the employment agreement, or by action of the Compensation Committee.
• The RSUs will be settled in shares of common stock and cash, with the cash portion approximately equal to federal, state, and local taxes.
• Shook also holds previously granted RSUs: 17,668 units (vesting 2026-2028), 15,372 units (vesting 2025-2027), and 3,981 units (vesting 2024-2026).
• Following this transaction, Shook beneficially owns a total of 60,741 Restricted Share Units (17,668 + 15,372 + 3,981 + 23,720).

Sentiment

Score: 7

Explanation: The filing indicates a routine executive compensation event, which is generally positive for executive retention and alignment with shareholder interests, but does not contain information that would significantly alter the company's financial outlook or operations.

Positives

• The grant of 23,720 Restricted Stock Units to a key executive aligns management incentives with shareholder interests.
• The equity award serves as a retention mechanism, requiring continuous employment for vesting over several years.

Risks

• The vesting of Restricted Stock Units is contingent on the reporting person's continuous employment, posing a risk of forfeiture if employment terminates prematurely for reasons other than specified accelerations (death, disability, Good Reason).

Future Outlook

The executive's future compensation is tied to the company's stock performance through the vesting of Restricted Stock Units over the next several years, with vesting schedules extending through 2029, indicating a long-term incentive structure.

Industry Context

The grant of Restricted Stock Units is a common form of executive compensation in publicly traded companies, particularly in the insurance or financial services sector where ProAssurance operates, used to align executive interests with long-term shareholder value and to retain key talent.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a significant component of executive compensation is a standard practice across various industries, including insurance, aligning executive incentives with long-term company performance and shareholder value.
• The multi-year, pro-rata vesting schedule (typically one-third per year over three years) is also a common structure designed for executive retention and sustained performance.
• Acceleration clauses for vesting upon death, disability, or 'Good Reason' termination are standard provisions in executive employment agreements and equity plans to provide protection and clarity in specific circumstances.

Related Party Transactions

• The grant of Restricted Stock Units to Kevin Merrick Shook, an officer of a subsidiary, constitutes a related party transaction as it involves compensation from the company to an executive.

Stakeholder Impact

• Shareholders: Potential positive impact due to increased alignment of executive incentives with long-term stock performance and retention of key management.
• Employees: No direct impact on general employees, but it signals continued executive compensation practices.
• Management: Direct positive impact through increased equity ownership and long-term incentive compensation.

Next Steps

• Vesting of 3,981 RSUs in 2024, 2025, and 2026.
• Vesting of 15,372 RSUs in 2025, 2026, and 2027.
• Vesting of 17,668 RSUs in 2026, 2027, and 2028.
• Vesting of 23,720 newly granted RSUs in 2027, 2028, and 2029.

Key Dates

Recommendation

This Form 4 filing details a routine executive equity grant and does not provide new information that would fundamentally change the investment thesis for ProAssurance Corporation. It reflects standard compensation practices aimed at executive retention and alignment, which are generally neutral to slightly positive, but not significant enough to warrant a change in investment recommendation based solely on this filing.

Keywords

ProAssurance, PRA, Restricted Stock Units, RSU, Equity Compensation, Executive Compensation, Form 4, Insider Transaction, Kevin Shook, Stock Grant